Page last updated: 2024-11-02

oxymetazoline and Heart Failure

oxymetazoline has been researched along with Heart Failure in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forster, C1
Campbell, PM1
Armstrong, PW1

Other Studies

1 other study available for oxymetazoline and Heart Failure

ArticleYear
Temporal alterations in peripheral vascular responsiveness during both the development and recovery from pacing-induced heart failure.
    Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:2

    Topics: Adrenergic alpha-Agonists; Animals; Arteries; Azepines; Cardiac Pacing, Artificial; Dinoprost; Dogs;

1992